Horvath, D., Temperton, N., Mayora-Neto, M., Cantoni, D., Horlacher, R., Günther, A., Brosig, A., Morath, J., Jakobs, B., Groettrup, M., Hoschuetzky, H., Rohayem, J. & ter Meulen, J. 2023, 'Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice', Scientific Reports, 13, article no: 4648. https://doi.org/10.1038/s41598-023-31198-3